{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T02:24:55Z","timestamp":1788229495795,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann. Intensive Care"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polymyxin B hemoperfusion (PMX) aims to treat septic shock by removing endotoxin from the patient\u2019s blood. However, the relationship between the severity of the patient's organ damage and the survival benefit of PMX treatment is not clear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed the efficacy of PMX on adult sepsis patients using the propensity score matching method and the Japanese Diagnosis Procedure Combination (DPC) national inpatient database from April 2018 to March 2020. We stratified the patients into five categories based on their baseline Sequential Organ Failure Assessment (SOFA) score and compared the mortality between PMX-treated and non-treated groups in each category. We also compared continuous hemodiafiltration (CHDF)-, ventilator- and noradrenaline-free days between the groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 44,177 patients included in the study, 2191 received PMX. After 1:1 propensity score matching, we created matched cohorts of 2033 pairs. PMX significantly improved the survival of the patients in the SOFA score categories of 7\u20139 and 10\u201312. On the other hand, there was no significant difference in the survival rate in SOFA score categories of 0\u20136, 13\u201315, and 16\u201324. In analyzing organ support-free days, PMX was also beneficial in the 7\u20139 and 10\u201312 SOFA categories compared to other categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Analysis of a large-scale Japanese inpatient database found a significant association between PMX efficacy and baseline SOFA score. This result indicates higher efficacy in patients with medium SOFA scores in the range of 7\u201312. The result provides a promising hypothesis for selecting appropriate patients for PMX and should be validated in future RCTs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13613-021-00928-z","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T17:04:34Z","timestamp":1632675874000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Effectiveness of polymyxin B hemoperfusion for sepsis depends on the baseline SOFA score: a nationwide observational study"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2199-7172","authenticated-orcid":false,"given":"Kenji","family":"Fujimori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunio","family":"Tarasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyohide","family":"Fushimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"key":"928_CR1","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study. Lancet. 2020;395:200\u201311.","journal-title":"Lancet"},{"key":"928_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1056\/NEJMoa1500896","volume":"372","author":"PR Mouncey","year":"2015","unstructured":"Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med. 2015;372:1301\u201311.","journal-title":"N Engl J Med"},{"key":"928_CR3","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1056\/NEJMoa1401602","volume":"370","author":"DM Yealy","year":"2014","unstructured":"ProCESS Investigators, Yealy DM, Kellum JA, Huang DT, Barnato AE, Weissfeld LA, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med. 2014;370:1683\u201393","journal-title":"N Engl J Med"},{"key":"928_CR4","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1056\/NEJMoa1404380","volume":"371","author":"SL Peake","year":"2014","unstructured":"ARISE Investigators; ANZICS Clinical Trials Group, Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med. 2014;371:1496\u2013506","journal-title":"N Engl J Med"},{"key":"928_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/cc13912","volume":"18","author":"C Ronco","year":"2014","unstructured":"Ronco C, Klein DJ. Polymyxin B hemoperfusion: a mechanistic perspective. Crit Care. 2014;18:309.","journal-title":"Crit Care"},{"key":"928_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1046\/j.1526-0968.2003.00005.x","volume":"7","author":"H Shoji","year":"2003","unstructured":"Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial. 2003;7:108\u201314.","journal-title":"Ther Apher Dial"},{"key":"928_CR7","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1001\/jama.2009.856","volume":"301","author":"DN Cruz","year":"2009","unstructured":"Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA. 2009;301:2445\u201352.","journal-title":"JAMA"},{"key":"928_CR8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s00134-015-3751-z","volume":"41","author":"DM Payen","year":"2015","unstructured":"Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Intensive Care Med. 2015;41:975\u201384.","journal-title":"Intensive Care Med"},{"key":"928_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2018.14618","volume":"320","author":"RP Dellinger","year":"2018","unstructured":"Dellinger RP, Bagshaw SM, Antonelli M, Foster DM, Klein DJ, Marshall JC, et al. effect of targeted polymyxin B hemoperfusion on 28-day mortality in patients with septic shock and elevated endotoxin level: the EUPHRATES randomized clinical trial. JAMA. 2018;320:1455\u201363.","journal-title":"JAMA"},{"key":"928_CR10","first-page":"55","volume":"4","author":"S Matsuda","year":"2010","unstructured":"Matsuda S, Fujimori K, Fushimi K. Development of casemix based evaluation system in Japan. Asian Pac J Dis Manag. 2010;4:55\u201366.","journal-title":"Asian Pac J Dis Manag"},{"key":"928_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1620\/tjem.223.1","volume":"223","author":"A Murata","year":"2011","unstructured":"Murata A, Matsuda S, Kuwabara K, Ichimiya Y, Fujino Y, Kubo T, et al. Equivalent clinical outcomes of bleeding peptic ulcers in teaching and non-teaching hospitals: evidence for standardization of medical care in Japan. Tohoku J Exp Med. 2011;223:1\u20137.","journal-title":"Tohoku J Exp Med"},{"key":"928_CR12","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130\u20139.","journal-title":"Med Care"},{"key":"928_CR13","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1097\/MLR.0b013e3181484347","volume":"45","author":"V Sundararajan","year":"2007","unstructured":"Sundararajan V, Quan H, Halfon P, Fushimi K, Luthi JC, Burnand B, et al. Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care. 2007;45:1210\u20135.","journal-title":"Med Care"},{"key":"928_CR14","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1097\/CCM.0000000000000150","volume":"42","author":"M Iwagami","year":"2014","unstructured":"Iwagami M, Yasunaga H, Doi K, Horiguchi H, Fushimi K, Matsubara T, et al. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis. Crit Care Med. 2014;42:1187\u201393.","journal-title":"Crit Care Med"},{"key":"928_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000444474","volume":"42","author":"M Iwagami","year":"2016","unstructured":"Iwagami M, Yasunaga H, Noiri E, Horiguchi H, Fushimi K, Matsubara T, et al. Potential survival benefit of polymyxin B hemoperfusion in septic shock patients on continuous renal replacement therapy: a propensity-matched analysis. Blood Purif. 2016;42:9\u201317.","journal-title":"Blood Purif"},{"key":"928_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1159\/000513213","volume":"50","author":"K Fujimori","year":"2021","unstructured":"Fujimori K, Tarasawa K, Fushimi K. Effects of Polymyxin B hemoperfusion on septic shock patients requiring noradrenaline: analysis of a nationwide administrative database in Japan. Blood Purif. 2021;50:560\u20136.","journal-title":"Blood Purif"},{"key":"928_CR17","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/1744-9987.13655","volume":"25","author":"K Fujimori","year":"2021","unstructured":"Fujimori K, Tarasawa K, Fushimi K. Effects of Polymyxin B hemoperfusion in patients with sepsis requiring continuous hemodiafiltration: analysis of a nationwide administrative database in Japan. Ther Apher Dial. 2021;25:384\u20139.","journal-title":"Ther Apher Dial"},{"key":"928_CR18","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00134-018-5463-7","volume":"44","author":"DJ Klein","year":"2018","unstructured":"Klein DJ, Foster D, Walker PM, Bagshaw SM, Mekonnen H, Antonelli M. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Intensive Care Med. 2018;44:2205\u201312.","journal-title":"Intensive Care Med"},{"key":"928_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40560-019-0386-0","volume":"7","author":"T Iba","year":"2019","unstructured":"Iba T, Klein DJ. The wind changed direction and the big river still flows: from EUPHRATES to TIGRIS. J Intensive Care. 2019;7:31.","journal-title":"J Intensive Care"},{"key":"928_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1177\/1753425913516885","volume":"20","author":"T Ikeda","year":"2014","unstructured":"Ikeda T, Ikeda K, Suda S, Ueno T. Usefulness of the endotoxin activity assay as a biomarker to assess the severity of endotoxemia in critically ill patients. Innate Immun. 2014;20:881\u20137.","journal-title":"Innate Immun"},{"key":"928_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10047-016-0922-9","volume":"20","author":"S Chihara","year":"2017","unstructured":"Chihara S, Masuda Y, Tatsumi H, Nakano K, Shimada T, Murohashi T, et al. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock. J Artif Organs. 2017;20:71\u20135.","journal-title":"J Artif Organs"},{"key":"928_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/ams2.446","volume":"7","author":"T Tanaka","year":"2019","unstructured":"Tanaka T, Tabata T, Fujino K, Tsujita Y, Eguchi Y. Impact of timing of polymyxin B-immobilized fiber column direct hemoperfusion on outcome in patients with septic shock: a single-center observational study. Acute Med Surg. 2019;7: e446. https:\/\/doi.org\/10.1002\/ams2.446.","journal-title":"Acute Med Surg"},{"key":"928_CR23","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/SHK.0000000000001533","volume":"54","author":"H Nakata","year":"2020","unstructured":"Nakata H, Yamakawa K, Kabata D, Umemura Y, Ogura H, Gando S, et al. Identifying septic shock populations benefitting from Polymyxin B hemoperfusion: a prospective cohort study incorporating a restricted cubic spline regression model. Shock. 2020;54:667\u201374.","journal-title":"Shock"},{"key":"928_CR24","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"JL Vincent","year":"1996","unstructured":"Vincent JL, Moreno R, Takala J, Willatts S, De Mendon\u00e7a A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707\u201310.","journal-title":"Intensive Care Med"},{"key":"928_CR25","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1001\/jama.2016.20328","volume":"317","author":"EP Raith","year":"2017","unstructured":"Raith EP, Udy AA, Bailey M, McGloughlin S, MacIsaac C, Bellomo R, et al. Prognostic accuracy of the SOFA score, SIRS criteria, and qSOFA score for in-hospital mortality among adults with suspected infection admitted to the intensive care unit. JAMA. 2017;317:290\u2013300.","journal-title":"JAMA"},{"key":"928_CR26","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-021-00928-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13613-021-00928-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13613-021-00928-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T06:41:05Z","timestamp":1767768065000},"score":1,"resource":{"primary":{"URL":"https:\/\/annalsofintensivecare.springeropen.com\/articles\/10.1186\/s13613-021-00928-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["928"],"URL":"https:\/\/doi.org\/10.1186\/s13613-021-00928-z","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the Tokyo Medical and Dental University, which waived the requirement for informed patient consent because of the anonymous nature of the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}